Point72 Middle East FZE’s CONMED CNMD Stock Holding History

Point72 Middle East FZE’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,551	Closed	-$1.59M	–	282
2023 Q4	$1.59M	Buy	+14,551	New	+$1.5M	0.05%	455

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Middle East FZE's CNMD Position: Q1 2024 in Review

Point72 Middle East FZE sold out of CONMED (CNMD) in Q1 2024, closing a stake of 14,551 shares — an estimated $1.59M sold.

Point72 Middle East FZE first reported a position in CNMD in Q4 2023 and held it in 1 quarter. The position peaked at $1.59M in Q4 2023. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

Point72 Middle East FZE reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
Point72 Middle East FZE sold 14,551 CONMED shares in Q1 2024, an estimated $1.59M.
Point72 Middle East FZE first reported a position in CONMED in Q4 2023 and held it in 1 quarter.
Point72 Middle East FZE's CONMED position peaked at $1.59M in Q4 2023.
298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.